OTC Healthcare in New Zealand
Euromonitor International's OTC Healthcare in New Zealand market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 127 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Slight growth for OTC
OTC healthcare was slightly up in 2008 against 2007. Despite continued current value growth, this upward movement was observed to be a slower than seen in 2007, mainly due to the maturity of many OTC healthcare product types in New Zealand. Good growth was experienced by NRT smoking cessation aids and emergency contraception, while underperformers were OTC obesity and analgesics.
Smoking continues downward trend
NRT smoking cessation aids experienced tremendous current value terms growth in 2008 compared with 2007, as smoking continues to be frowned upon by the health authorities. Education in schools and strong TV advertising campaigns, together with legislative on-pack “cancer graphics” have made smoking increasingly portrayed as an “outcast” habit, and strongly socially unacceptable in many circles. The Quit campaign heavily endorses NRT smoking cessation products, with particular products being government-funded, so smokers can have assistance to give up smoking.
Multinationals continue to take top spots
Multinational companies continue to dominate overall in the OTC healthcare environment, with Reckitt Benckiser New Zealand Ltd remaining in the top spot, followed by Johnson & Johnson Pacific (NZ) Ltd and GlaxoSmithKline New Zealand Ltd respectively. The top New Zealand company – Healtheries of New Zealand Ltd – ranked fourth due to its strength in nutritionals. 2008 saw the Sanofi-Aventis acquisition of Symbion Health, which is strong in nutritional products. This merger of pharmaceuticals and nutritionals is expected to put Sanofi-Aventis in a stronger position over the forecast period.
Chemists/pharmacies channel bounces back
After a slight decline in distribution value share over 2006-7, chemists/pharmacies sales regained share in 2008, particularly in nutritional products. Pharmacy banners have made a concerted effort to bring back consumers through the chemists/pharmacies channel. Initiatives such as Family Health Diary on TV, which informs consumers of products available through the pharmacy, and setting up of “allergy centres” within pharmacies, has seen a shift back in sales. All main pharmacy banners saw an increase in outlets in 2008. Life Pharmacy Ltd has expanded and introduced Life Pharmacy Metro – a city-style chemist to meet the needs of consumers with busy lifestyles – and acquired the Care Chemist Service chain in May 2008. Unichem remains the largest pharmacy banner in terms of outlets, and is portrayed as the “community chemist”.
Gradual growth forecast
Over the forecast period OTC healthcare products are expected to see slower growth compared with the review period. This is mainly due to the maturing of many product types within the OTC healthcare environment in New Zealand. As more products are re-scheduled for “general sale” this opens the door for distribution through grocery outlets, with an consequent shift in focus towards volume over value. However, most healthcare OTC products are expected to remain pharmacy-driven, which will stimulate growth in value terms. Many players are expected to revitalise maturing categories through product innovation, brand extension and targeting niche growth areas.
Table of contents
OTC HEALTHCARE IN NEW ZEALAND : MARKET INSIGHT
EXECUTIVE SUMMARY
Slight growth for OTC
Smoking continues downward trend
Multinationals continue to take top spots
Chemists/pharmacies channel bounces back
Gradual growth forecast
KEY TRENDS AND DEVELOPMENTS
Leveraging brand power
Herbal remedies grow stronger
Further product segmentation
Multinationals remain strong
Pharmacy outlets expand
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
DEFINITIONS
Summary 2 Research Sources
LOCAL COMPANY PROFILES - NEW ZEALAND
COMVITA NEW ZEALAND LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Comvita Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Comvita Limited: Competitive Position 2008
DOUGLAS PHARMACEUTICALS LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Douglas Pharmaceuticals Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 6 Douglas Pharmaceuticals Ltd: Competitive Position 2008
NUTRA-LIFE HEALTH & FITNESS (NZ) LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Nutra-Life Health & Fitness (NZ) Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 8 Nutra-Life Health & Fitness (NZ) Ltd: Competitive Position 2008
PACIFIC PHARMACEUTICALS LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Pacific Pharmaceuticals Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Pacific Pharmaceuticals Ltd: Competitive Position 2008
PSM HEALTHCARE LTD - OTC HEALTHCARE - NEW ZEALAND
STRATEGIC DIRECTION
KEY FACTS
Summary 11 PSM Healthcare Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 12 PSM Healthcare Ltd: Competitive Position 2008
ANALGESICS IN NEW ZEALAND
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2003-2008
Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 14 Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 16 Analgesics Company Shares by Value 2004-2008
Table 17 Analgesics Brand Shares by Value 2005-2008
Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN NEW ZEALAND
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 22 Sales of Decongestants by Type: Value 2003-2008
Table 23 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 25 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 26 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 28 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 30 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN NEW ZEALAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 31 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 32 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 33 Herbal vs Standard Digestive Remedies 2003-2008
Table 34 Digestive Remedies Company Shares by Value 2004-2008
Table 35 Digestive Remedies Brand Shares by Value 2005-2008
Table 36 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 37 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN NEW ZEALAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 38 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 39 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 40 Herbal vs Standard Medicated Skin Care 2003-2008
Table 41 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 42 Medicated Skin Care Company Shares by Value 2004-2008
Table 43 Medicated Skin Care Brand Shares by Value 2005-2008
Table 44 Acne Treatments Brand Shares by Value 2005-2008
Table 45 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 46 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 47 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN NEW ZEALAND
HEADLINES
TRENDS – VITAMINS
TRENDS – DIETARY SUPPLEMENTS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 48 Dietary Supplements: Brand Ranking by Positioning 2008 Low Calorie Carbonates by Niche
Table 49 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 50 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 51 Folic Acid v Other B Vitamins 2004-2008
Table 52 Dietary Supplements by Positioning 2006-2008
Table 53 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 54 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 55 Vitamins Brand Shares by Value 2005-2008
Table 56 Dietary Supplements Brand Shares by Value 2005-2008
Table 57 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 58 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN NEW ZEALAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 59 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 60 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 61 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 62 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 63 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 64 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 65 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 66 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE IN NEW ZEALAND
HEADLINES
SECTOR DATA
Table 67 Sales of Eye Care by Subsector: Value 2003-2008
Table 68 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 69 Standard Eye Care by Type: % Value Breakdown 2007-2008
Table 70 Eye Care Company Shares by Value 2004-2008
Table 71 Eye Care Brand Shares by Value 2005-2008
Table 72 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 73 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
EAR CARE IN NEW ZEALAND
HEADLINES
SECTOR DATA
Table 74 Sales of Ear Care: Value 2003-2008
Table 75 Sales of Ear Care: % Value Growth 2003-2008
Table 76 Ear Care Company Shares by Value 2004-2008
Table 77 Ear Care Brand Shares by Value 2005-2008
Table 78 Forecast Sales of Ear Care: Value 2008-2013
Table 79 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN NEW ZEALAND
HEADLINES
SECTOR DATA
Table 80 Sales of Adult Mouth Care: Value 2003-2008
Table 81 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 82 Adult Mouth Care Company Shares by Value 2004-2008
Table 83 Adult Mouth Care Brand Shares by Value 2005-2008
Table 84 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 85 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN NEW ZEALAND
HEADLINES
SECTOR DATA
Table 86 Sales of Calming and Sleeping Products: Value 2003-2008
Table 87 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 88 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 89 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 90 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 91 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
WOUND TREATMENTS IN NEW ZEALAND
HEADLINES
SECTOR DATA
Table 92 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 93 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 94 Wound Treatments Company Shares by Value 2004-2008
Table 95 Wound Treatments Brand Shares by Value 2005-2008
Table 96 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 97 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
OTC OBESITY IN NEW ZEALAND
HEADLINES
SECTOR DATA
Table 98 Sales of OTC Obesity: Value 2005-2008
Table 99 Sales of OTC Obesity: % Value Growth 2005-2008
Table 100 OTC Obesity Company Shares by Value 2005-2008
Table 101 OTC Obesity Brand Shares by Value 2005-2008
Table 102 Forecast Sales of OTC Obesity: Value 2008-2013
Table 103 Forecast Sales of OTC Obesity: % Value Growth 2008-2013
EMERGENCY CONTRACEPTION IN NEW ZEALAND
HEADLINES
SECTOR DATA
Table 104 Sales of Emergency Contraception: Value 2003-2008
Table 105 Sales of Emergency Contraception: % Value Growth 2003-2008
Table 106 Emergency Contraception Company Shares by Value 2004-2008
Table 107 Emergency Contraception Brand Shares by Value 2005-2008
Table 108 Forecast Sales of Emergency Contraception: Value 2008-2013
Table 109 Forecast Sales of Emergency Contraception: % Value Growth 2008-2013
OTC TRIPTANS IN NEW ZEALAND
HEADLINES
SECTOR DATA
Table 110 Sales of OTC Triptans: Value 2007-2008
Table 111 Sales of OTC Triptans: % Value Growth 2007-2008
Table 112 OTC Triptans Company Shares by Value 2007-2008
Table 113 OTC Triptans Brand Shares by Value 2007-2008
Table 114 Forecast Sales of OTC Triptans: Value 2008-2013
Table 115 Forecast Sales of OTC Triptans: % Value Growth 2008-2013